From CNBC:

Medicare can now cover certain weight loss drugs with added health benefits, such as Novo Nordisk’s Wegovy. This change allows broader coverage of popular weight loss medications previously not covered. Drugmakers like Novo Nordisk and Eli Lilly are testing these drugs for additional health conditions, potentially leading to increased coverage in the future. Around 50 million Americans with obesity have insurance coverage for weight loss drugs. However, many employers do not cover these medications. A new law prohibits Medicare Part D plans from covering weight loss drugs, but bipartisan lawmakers are pushing for legislative changes. By law, Medicaid must cover Wegovy for its new cardiovascular use, and around 1 in 5 state Medicaid programs currently cover GLP-1 drugs for weight loss.



Read more at CNBC: Medicare can cover weight loss drugs if used for added health benefit